Open Access Open Access  Restricted Access Subscription or Fee Access

Potential Role of Unani Herbs in Management of Hypertensive Cardiomyopathy: A Review

Mulla Abdul Wahid, Mohd Khalid, Khan Azhar Hasan, Mariyam Roqaiya, Hina Fatima


Hypertensive cardiomyopathy (HTN-CM) is a structural heart disease associated with concentric left ventricular hypertrophy (LVH) along with systolic or diastolic dysfunction in primary hypertensive patients in the absence of other cardiac diseases causing myocardial hypertrophy or cardiac dysfunction. The structural and functional myocardial abnormalities due to persistent hypertension result in myocardial ischemia, fibrosis, and hypertrophy. HTN-CM is primarily a disease of impaired ventricular relaxation rather than impaired contractility; thus patients are generally asymptomatic in resting conditions, but the stiff left ventricles do not properly relax in strenuous conditions and cannot generate appropriate cardiac output. The concomitant LVH is itself a major risk factor for mortality and morbidity in hypertensive patients. Therefore, early detection of hypertensive cardiomyopathy is vital for the treatment corroborated with pathological findings, echocardiography and cardiac magnetic resonance imaging. Extensive research work has been done on essential hypertension in Unani medicine with promising results based on the removal of vascular congestion (Imtila bi Hasbil Auiya), and the same treatment basics may be applied in management of hypertensive cardiomyopathy. Drugs like Arjuna (Terminalia arjuna ROXB.), Tabasheer (Bambusa arundinacea Wild.), Jadwar (Delphinum denudatum Wall.), Zafran (Crocus sativus L.), and Asrol (Rauvolfia serpentina L.) are scientifically reported for their potent efficacy in management of essential hypertension and the resultant cardiomyopathy. As the major research has been focused on management of essential hypertension; the present review will focus on hypertensive cardiomyopathy highlighting the foreseen effects of Unani herbs, their mechanism of actions, metabolic targets, possible future research avenues, and limitations in view of available scientific data.

Keywords: hypertension; cardiomyopathy; Arjuna; Unani

Cite this Article
Mulla Abdul Wahid, Mohd Khalid, Khan Azhar Hasan, Mariyam Roqaiya, Hina Fatima. Potential Role of Unani Herbs in Management of Hypertensive Cardiomyopathy: A Review. Research & Reviews: A Journal of Unani, Siddha and Homeopathy . 2020; 9(1): 1–6p.


hypertension; cardiomyopathy; Arjuna; Unani

Full Text:



Kamath SA. In API Textbook of Medicine: Hypertension and its management. 10th edition. New Delhi: Jaypee Medical Publishers and Distributors; 2015:916-920.

R. Gupta et al. Emerging trends in hypertension epidemiology in India. Journal of Human Hypertension. 2018

Holl MJ, van de Poll SW, Michels M. Complete reversal of hypertensive cardiomyopathy after initiating combined antihypertensive therapy. BMJ Case Rep 2016; 1-4

King TC. Elsevier’s integrated pathology. 1st edition. Philadelphia: Mosby Elsevier. 2007: 181-182.

Musilli C et al. Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients. Mol Immunol 2011; 49: 234-238.

Iriarte M et al. Classification of hypertensive cardiomyopathy. Eur Heart J. 1993;14:95-101

Nadruz W. Myocardial remodeling in hypertension. J Hum Hypertens 2015; 29: 1-6

van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 1990; 82: 848-855

Janardhanan R, Kramer CM. Imaging in hypertensive heart disease. Expert Rev Cardiovasc Ther 2011; 9: 199-209

Cuspidi C, Ciulla M, Zanchetti A. Hypertensive myocardial fibrosis. Nephrol Dial Transplant 2006; 21: 20-23

Cuspidi et al Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens 2012; 26: 343-349

Lassègue B, San Martín A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circulation research. 2012; 110:1364-1390

Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxidants & redox signaling. 2006; 8:691-728

Wang P, Tang F, Li R, Zhang H, Chen S, Liu P, Huang H. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan. Pharmacological research. 2007; 55:408-417

Murdoch CE, Zhang M, Cave AC, Shah AM. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovascular research. 2006; 71:208-215

Sulistyowati E, Hsu JH, Cheng YB, Chang FR, Chen YF, Yeh JL. Indonesian herbal medicine prevents hypertension-induced left ventricular hypertrophy by diminishing NADPH oxidase-dependent oxidative stress. Oncotarget. 2017; 8(49):86784-86798.

Al Disi SS, Anwar MA, Eid AH. Anti-hypertensive Herbs and their Mechanisms of Action: Part I. Front Pharmacol. 2016;6:323

Benavides GA etal. Hydrogen sulfide mediates the vasoactivity of garlic. Proc.Natl. Acad.Sci.U.S.A. 104,17977–17982. [accessed on 26.12.2018]

Joukar S, Asadipour H, Sheibani M, Najafipour H, Dabiri S. The effects of Melissa officinalis (lemon balm) pretreatment on the resistance of the heart to myocardial injury. Pharm Biol. 2016;54(6):1005-13.

S. Zheng, Z. Qian, N. Wen, L. Xi, Crocetin suppresses angiotensin II-induced vascular smooth-muscle cell proliferation through inhibition of ERK1/2 activation and cell-cycle progression, J. Cardiovasc. Pharmacol. 2007; 50 (5): 519–525.

Hara Y et al. Effects of aged garlic extract on left ventricular diastolic function and fibrosis in a rat hypertension model. Exp Anim. 2013;62(4):305-10.

Anwar MA, Al Disi SS, Eid AH. Anti-Hypertensive Herbs and Their Mechanisms of Action: Part II. Front Pharmacol. 2016;7:50.

Lobay D. Rauwolfia in the treatment of hypertension. Integr Med (Encinitas). 2015;14(3):40-6.

Kumar S et al. Proteomic analysis of the protective effects of aqueous bark extract of Terminalia arjuna (Roxb.) on isoproterenol-induced cardiac hypertrophy in rats. J Ethnopharmacol. 2017;198:98-108.


  • There are currently no refbacks.